Stacie Corcoran
Memorial Sloan Kettering Cancer Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stacie Corcoran.
Journal of Clinical Oncology | 2016
Joanne Frankel Kelvin; Bridgette Thom; Catherine Benedict; Jeanne Carter; Stacie Corcoran; Maura N. Dickler; Karyn A. Goodman; Allison Margolies; Matthew J. Matasar; Ariela Noy; Shari Goldfarb
PURPOSEnA cancer and fertility program was established at a large cancer center to support clinicians in discussing treatment-related fertility risks and fertility preservation (FP) options with patients and in referring patients to reproductive specialists. The program provides resources, clinician education, and fertility clinical nurse specialist consultation. This study evaluated the programs impact on patient satisfaction with information received.nnnPATIENTS AND METHODSnRetrospective cross-sectional surveys assessed satisfaction before (cohort 1 [C1]) and after (cohort 2 [C2]) program initiation. Questionnaires were investigator-designed, gender-specific, and anonymous.nnnRESULTSnMost C1 (150 males, 271 females) and C2 (120 males, 320 females) respondents were 2 years postdiagnosis; the most frequently reported cancers were testicular, breast, and lymphoma. A significant difference in satisfaction with the amount of information received was seen between C1 and C2. For males, satisfaction with information on fertility risks was high in both cohorts but significantly greater in C2 for information on sperm banking (χ(2) = 9.3, P = .01) and finding a sperm bank (χ(2) = 13.3, P = .001). For females, satisfaction with information was significantly greater in C2 for information on fertility risks (χ(2) = 62.1, P < .001), FP options (χ(2) = 71.9, P < .001), help with decision making (χ(2) = 80.2, P < .001), and finding a reproductive endocrinologist (χ(2) = 60.5, P < .001). Among patients who received and read information materials, 96% of males and 99% of females found them helpful. Among C2 females, fertility clinical nurse specialist consultation was associated with significantly greater satisfaction with information on FP options (χ(2) = 11.2, P = .004), help with decision making (χ(2) = 10.4, P = .006), and finding a reproductive endocrinologist (χ(2) = 22.6, P < .001), with 10% reporting lack of knowledge as a reason for not pursuing FP.nnnCONCLUSIONnImprovements in patient satisfaction with information received demonstrate the potential for fertility programs in cancer care settings to improve the quality of clinician-patient discussions about fertility.
Seminars in Oncology Nursing | 2015
Stacie Corcoran; Megan Dunne; Mary S. McCabe
OBJECTIVESnTo review advanced practice nursing roles in planning, implementing, and evaluating survivorship care.nnnDATA SOURCESnReview of the literature, published articles, government and organizational reports.nnnCONCLUSIONnThe increased focus on improving post-treatment cancer care presents opportunities for advanced practice nurses to meet the physical and psychosocial needs of cancer survivors.nnnIMPLICATIONS FOR NURSING PRACTICEnAs experts in the comprehensive delivery of care, oncology advanced practice nurses are positioned to initiate, deliver, and evaluate survivorship care through innovative models.
Pilot and Feasibility Studies | 2016
Talya Salz; Mary S. McCabe; Kevin C. Oeffinger; Stacie Corcoran; Andrew J. Vickers; Andrew L. Salner; Ellen A. Dornelas; Rebecca Schnall; Nirupa Jaya Raghunathan; Elizabeth Fortier; Shrujal S. Baxi
BackgroundHead and neck cancer survivors commonly experience severe long-term toxicities, late-occurring symptoms, and significant risks of the second primary malignancy and comorbid illnesses. With multiple simultaneous health issues, these complex cancer survivors often do not receive comprehensive health care that addresses their needs. A tool is needed to streamline and standardize comprehensive care for this cohort.Methods/designWe designed the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR) to address health care challenges for head and neck cancer survivors. HN-STAR is an electronic platform that aims to simplify the provision of personalized care in cancer survivorship clinics. It uses an algorithmic approach to integrate patient-reported outcomes, clinical details, and evidence-based guidelines to standardize comprehensive care provided in routine survivorship visits. It has four integrated components: (1) a simplified treatment summary, which pulls treatment details from a clinical database or can be completed manually using a streamlined form; (2) an online self-assessment for patients to report their own symptoms; (3) an interactive discussion guide presenting all relevant information to the provider during the clinic visit; and (4) a survivorship care plan generated at the end of each visit that reflects decisions made during the visit. By using a modifiable electronic platform, HN-STAR provides a method for incorporating survivorship care plans into clinical practice and for disseminating evidence on symptom management and preventive care.This is a study to assess the feasibility of a future multi-site, randomized clinical trial of HN-STAR. We will enroll head and neck cancer survivors who are followed in one of two nurse practitioner-led survivorship clinics. We will implement HN-STAR for one routine survivorship visits. We will assess (1) usability and feasibility outcomes of HN-STAR from the perspective of key stakeholders and (2) the planned outcomes intended for the larger trial. We will collect usability and feasibility data from online surveys of survivors and their providers. Our findings will inform whether it is feasible to advance HN-STAR to trial. If so, we will adapt HN-STAR and the study design of the trial in response to feedback from survivors and providers. The long-term goal is to determine if such an intervention will lead to improved and simplified comprehensive survivorship care.DiscussionThis feasibility study will evaluate implementation of HN-STAR into clinical practice in terms of usability, practicality, and clinical flow in two distinct clinical settings. This study will also provide critical baseline data to characterize this vulnerable population. Findings from this study will inform a multicenter randomized trial of HN-STAR, aimed at standardizing and streamlining the delivery of evidence-guided comprehensive care for head and neck cancer survivors. Ultimately, if found effective, the modular structure of HN-STAR could permit its expansion to survivors of other complex cancers.Trial registrationClinicalTrials.gov, NCT02571673
JCO Clinical Cancer Informatics | 2018
Talya Salz; Rebecca Schnall; Mary S. McCabe; Kevin C. Oeffinger; Stacie Corcoran; Andrew J. Vickers; Andrew L. Salner; Ellen A. Dornelas; Nirupa Jaya Raghunathan; Elizabeth Fortier; Janet McKiernan; David Finitsis; Susan Chimonas; Shrujal S. Baxi
PURPOSEnTo improve the care of survivors of head and neck cancer, we developed the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR). HN-STAR is an electronic platform that incorporates patient-reported outcomes into a clinical decision support tool for use at a survivorship visit. Selections in the clinical decision support tool automatically populate a survivorship care plan (SCP). We aimed to refine HN-STAR by eliciting and incorporating feedback on its ease of use and usefulness.nnnMETHODSnHuman-computer interaction (HCI) experts reviewed HN-STAR using think-aloud testing and the Nielsen Heuristic Checklist. Nurse practitioners (NPs) thought aloud while reviewing the clinical decision support tool and SCP and responded to an interview. Survivors used HN-STAR as part of a routine visit and were interviewed afterward. We analyzed themes from the feedback. We described how we addressed each theme to improve the usability of HN-STAR.nnnRESULTSnFive HCI experts, 10 NPs, and 10 cancer survivors provided complementary usability insight that we categorized into themes of improvements. For ease of use, themes included technical design considerations to enhance user interface, ease of completion of a self-assessment, streamlining text, disruption of the clinic visit, and threshold for symptoms to appear on the SCP. The theme addressing usefulness was efficiency and comprehensiveness of the clinic visit. For each theme, we report revisions to HN-STAR in response to the feedback.nnnCONCLUSIONnHCI experts provided key technical design insights into HN-STAR, whereas NPs and survivors provided usability feedback and clinical perspectives. We incorporated the feedback into the preparation for additional testing of HN-STAR. This method can inform and improve the ease of use and usefulness of the survivorship applications.
Journal of Clinical Oncology | 2016
Mary S. McCabe; Annelies H. Boekhout; Bridgette Thom; Stacie Corcoran; Roberto Adsuar; Kevin C. Oeffinger
Journal of Clinical Oncology | 2018
Stacie Corcoran; Bridgette Thom; Katie Decker
Journal of Clinical Oncology | 2018
Talya Salz; Andrew L. Salner; Nirupa Jaya Raghunathan; Mary S. McCabe; Ellen A. Dornelas; David Finitsis; Stacie Corcoran; Elizabeth Fortier; Ryan Weber; Amy Tin; Andrew J. Vickers; Kevin C. Oeffinger; Shrujal S. Baxi
Journal of Clinical Oncology | 2017
Talya Salz; Mary S. McCabe; Kevin C. Oeffinger; Rebecca Schnall; Stacie Corcoran; Andrew J. Vickers; Andrew L. Salner; Ellen A. Dornelas; Nirupa Jaya Raghunathan; Elizabeth Fortier; David Finitsis; Shrujal S. Baxi
Journal of Clinical Oncology | 2017
Carol S. Portlock; Paul A. Hamlin; John F. Gerecitano; Ariela Noy; Maria Lia Palomba; Janelle Walkley; Stacie Corcoran; Genovefa A. Papanicolaou; Arnold J. Markowitz
Tumor microenvironment and therapy | 2015
Carol S. Portlock; Paul A. Hamlin; John F. Gerecitano; Ariela Noy; Maria Lia Palomba; Janelle Walkley; Stacie Corcoran; Jocelyn C. Migliacci; Heiko Schöder; Genovefa A. Papanicolaou; Arnold J. Markowitz